MHC-I-restricted presentation of HIV-1 virion antigens without viral replication

被引:133
作者
Buseyne, F
Le Gall, S
Boccaccio, C
Abastado, JP
Lifson, JD
Arthur, LO
Rivière, Y
Heard, JM
Schwartz, O [1 ]
机构
[1] Inst Pasteur, Unite Retrovirus & Transfert Genet, Paris, France
[2] Inst Pasteur, Lab Immunopathol Virale, Paris, France
[3] Inst Cordeliers, ImmunoDesigned Mol Res Labs, Paris, France
[4] NCI, Retroviral Pathogenesis Lab, AIDS Vaccine Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA
关键词
D O I
10.1038/85493
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells and macrophages can process extracellular antigens for presentation by MHC-I molecules. This exogenous pathway may have a crucial role in the activation of CD8(+) cytotoxic T lymphocytes during human viral infections. We show here that HIV-1 epitopes derived from incoming virions are presented through the exogenous MHC-I pathway in primary human dendritic cells, and to a lower extent in macrophages, leading to cytotoxic T-lymphocyte activation in the absence of viral protein synthesis. Exogenous antigen presentation required adequate virus-receptor interactions and fusion of viral and cellular membranes. These results provide new insights into how anti-HIV cytotoxic T lymphocytes can be activated and have implications for anti-HIV vaccine design.
引用
收藏
页码:344 / 349
页数:6
相关论文
共 45 条
  • [31] ROCK KL, 1996, IMMUNOL TODAY, V17, P129
  • [32] Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
    Rodriguez, A
    Regnault, A
    Kleijmeer, M
    Ricciardi-Castagnoli, P
    Amigorena, S
    [J]. NATURE CELL BIOLOGY, 1999, 1 (06) : 362 - 368
  • [33] Rossiter J C, 1992, Contemp Nurse, V1, P75
  • [34] Role of cellular immunity in protection against HIV infection
    Rowland-Jones, S
    Tan, RS
    McMichael, A
    [J]. ADVANCES IN IMMUNOLOGY, VOL 65, 1997, 65 : 277 - 346
  • [35] HIV-SPECIFIC CYTOTOXIC T-CELLS IN HIV-EXPOSED BUT UNINFECTED GAMBIAN WOMEN
    ROWLANDJONES, S
    SUTTON, J
    ARIYOSHI, K
    DONG, T
    GOTCH, F
    MCADAM, S
    WHITBY, D
    SABALLY, S
    GALLIMORE, A
    CORRAH, T
    TAKIGUCHI, M
    SCHULTZ, T
    MCMICHAEL, A
    WHITTLE, H
    [J]. NATURE MEDICINE, 1995, 1 (01) : 59 - 64
  • [36] Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1
    Schwartz, O
    Maréchal, V
    Friguet, B
    Arenzana-Seisdedos, F
    Heard, JM
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (05) : 3845 - 3850
  • [37] Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
    Schwartz, O
    Marechal, V
    LeGall, S
    Lemonnier, F
    Heard, JM
    [J]. NATURE MEDICINE, 1996, 2 (03) : 338 - 342
  • [38] Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
    Sigal, LJ
    Crotty, S
    Andino, R
    Rock, KL
    [J]. NATURE, 1999, 398 (6722) : 77 - 80
  • [39] Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis
    Singh-Jasuja, H
    Toes, REM
    Spee, P
    Münz, C
    Hilf, N
    Schoenberger, SP
    Ricciardi-Castagnoli, P
    Neefjes, J
    Rammensee, HG
    Arnold-Schild, D
    Schild, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) : 1965 - 1974
  • [40] NATURALLY PROCESSED VIRAL PEPTIDES RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES ON CELLS CHRONICALLY INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TSOMIDES, TJ
    ALDOVINI, A
    JOHNSON, RP
    WALKER, BD
    YOUNG, RA
    EISEN, HN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1283 - 1293